ArticleJournal for immunotherapy of cancer2023
Correction: MDR1-expressing CD4+ T cells with Th1.17 features resist to neoadjuvant chemotherapy and are associated with breast cancer clinical response.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.